Evaluation of the fully automated, quantitative COBAS AmpliPrep/COBAS TaqMan HCV Test, a highly sensitive hepatitis C virus real-time PCR assay with broad measuring range

被引:0
|
作者
Sizmann, D [1 ]
Babiel, R [1 ]
Boeck, C [1 ]
Boelter, J [1 ]
Hoecht, P [1 ]
Jaeger, S [1 ]
Kyriosoglou, K [1 ]
Miethke, M [1 ]
Nicolaus, S [1 ]
Richter, M [1 ]
Zadak, M [1 ]
Zauke, M [1 ]
机构
[1] Roche Diagnost GmbH, Penzberg, Germany
关键词
D O I
10.1016/S0168-8278(04)90517-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
517
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [21] Multicenter Evaluation of Cobas HBV Real-Time PCR Assay on the Roche Cobas 4800 System in Comparison with COBAS AmpliPrep/COBAS TaqMan HBV Test: Leading Circle for Cobas 4800 Virology (LCCV) Project
    Kim, H.
    Hurt, M.
    Bae, E.
    Lee, K.
    Lee, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 979 - 979
  • [22] Performance Evaluation of the New Roche cobas AmpliPrep/cobas TaqMan HCV Test, Version 2.0, for Detection and Quantification of Hepatitis C Virus RNA
    Pas, S.
    Molenkamp, R.
    Schinkel, J.
    Rebers, S.
    Copra, C.
    Seven-Deniz, S.
    Thamke, D.
    de Knegt, R. J.
    Haagmans, B. L.
    Schutten, M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (01) : 238 - 242
  • [23] Evaluation of Architect anti-HCV Signal to Cutoff Ratios for Predicting Hepatitis C Viremia Using COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test
    He, Yuting
    Chen, Yao
    Wang, Yichong
    Chen, Xuefang
    Huang, Hao
    Yu, Xuegao
    He, Xiaohong
    Zeng, Wentao
    Liu, Min
    Huang, Bin
    Chen, Peisong
    CLINICAL LABORATORY, 2020, 66 (08) : 1543 - 1548
  • [24] The new Cobas AmpliPrep-Cobas TaqMan (CAP/CTM) real-time PCR assay accurately quantifies HCV genotype 4 RNA in blood
    Chevaliez, Stephane
    Bouvier-Alias, Magali
    Poveda, Jean-Dominique
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2012, 56 : 680A - 680A
  • [25] Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral therapy HCV RealTime assay, and Versant HCV RNA assay
    Tuaillon, Edouard
    Mondain, Anne-Maric
    Ottomani, Laure
    Roudiere, Laurent
    Perney, Pascal
    Picot, Marie-Christine
    Seguret, Fabienne
    Blanc, Francois
    Larrey, Dominique
    Van De Perre, Philippe
    Ducos, Jacques
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (09) : 3077 - 3081
  • [26] The Cobas AmpliPrep-Cobas TaqMan Real-Time Polymerase Chain Reaction Assay Fails To Detect Hepatitis C Virus RNA in Highly Viremic Genotype 4 Clinical Samples
    Chevaliez, Stephane
    Bouvier-Alias, Magali
    Castera, Laurent
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2009, 49 (04) : 1397 - 1398
  • [27] Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification
    Vermehren, Johannes
    Kau, Annika
    Gaertner, Barbara C.
    Goebel, Reinhild
    Zeuzem, Stefan
    Sarrazin, Christoph
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (12) : 3880 - 3891
  • [28] Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test
    Pierce, Virginia M.
    Eversley, Jacqueline S.
    Tran, Thuy K.
    Rosenberg, Eric S.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (07) : 956 - 961
  • [29] Evaluation of the Fluorion HCV QNP v3.0 real-time PCR assay for quantifying HCV RNA in Moroccan patients: A comparative study with COBAS AmpliPrep/COBAS TaqMan HCV v2.0
    Madihi, Salma
    Boukaira, Samia
    Bouafi, Hind
    Baha, Warda
    Belkadi, Bouchra
    Benani, Abdelouaheb
    GENE REPORTS, 2024, 36
  • [30] Evaluation of hepatitis C virus RNA stability in room temperature and multiple freeze-thaw cycles by COBAS AmpliPrep/COBAS TaqMan HCV
    Comert, Fusun
    Aktas, Elif
    Terzi, H. Agah
    Kulah, Canan
    Ustundag, Yucel
    Kokturk, Furuzan
    Aydemir, Selim
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (01) : 81 - 85